Health Care & Life Sciences » Pharmaceuticals | GreenPeptide Co. Ltd.

GreenPeptide Co. Ltd.

GreenPeptide Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY44.96
Market Cap
JPY11.63 B
Shares Outstanding
41.99 M
Public Float
40.61 M

Profile

Address
Fukuoka Bio Incubation Center 402
Kurume Fukuoka 839
Japan
Employees -
Website http://www.brightpathbio.com
Updated 07/08/2019
BrightPath Biotherapeutics Co., Ltd. engages in the drug development business. It focuses on the development of cancer immunotherapies. Its product candidates are based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.

Financials

View All
Created with Highcharts 5.0.14GreenPeptide Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Thousands.17 48517 485412 435412 435994 464994 4641 113 6611 113 6611 577 1431 577 1431 884 3181 884 3182014201520162017201820190500k1 000k1 500k2 000k
Created with Highcharts 5.0.14GreenPeptide Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Thousands.933 388933 388821 625821 625822 556822 556529 612529 612354 410354 410155 808155 8082014201520162017201820190250k500k750k1 000k

Kenichi Nagai
President, CEO & Representative Director
Yutaka Waki
COO, Director & Manager-Medicine Development